Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA
Mandate

VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA

September 19, 2014

Vinge assists a group of Swedish investors through AdvInvest AB in connection with its acquisition financing and acquisition through AdvInvest of a majority stake in Advania. Advania is a Nordic IT company with approx. 1,100 employees in 17 offices in Iceland, Sweden and Norway. Beringer Finance assisted AdvInvest as corporate finance advisor.

Vinge’s team consisted of among others responsible partner Henrik Wenckert (M&A) and project manager Peter Sundgren (M&A) as well as associates Louise Brorsson Salomon (Banking & Finance), Oscar Rydén (Banking & Finance), Albert Wållgren (Banking & Finance), Filip Brosset (M&A), Johan Wahlbom (EU & Competition), Evelina Tejle (Employment & Benefits), Nicklas Thorgerzon (Technology & Outsourcing), Rebecka Weitzberg (Intellectual Property) and Daniel Unger (Real Estate).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026